ALOX5 and urinary bladder carcinoma: Importantly, previous studies have identified ALOX5 as a key mediator of ferroptosis in various cancers, including melanoma and bladder cancer [18, 19], suggesting that ALOX5 expression may serve as an indicator of susceptibility to ferroptosis.